Probiotics for treating novel coronavirus with diarrhea: A protocol for systematic review and meta analysis.
Medicine (Baltimore)
; 99(38): e21617, 2020 Sep 18.
Article
in English
| MEDLINE | ID: covidwho-787417
ABSTRACT
BACKGROUND:
The study aims to evaluate the efficacy and safety of probiotic therapy for coronavirus disease 2019 with diarrhea.METHODS:
The following electronic bibliographic databases will be searched to identify relevant studies from December 2019 to December 2020 MEDLINE, PubMed, Embase, the Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, Chinese Technical Periodicals, Wan-fang data, Chinese Biological Medicine Database, and other databases. The search results will not be restricted by language, all included articles were randomized controlled trial. Two independent researchers will conduct article retrieval, de-duplication, filtering, quality assessment, and data analysis through the Review Manager (V.5.3). Meta-analysis, subgroup analysis and/or descriptive analysis were performed on the included data.RESULTS:
High-quality synthesis and/or descriptive analysis of current evidence will be provided from outcomes.CONCLUSION:
This study will provide the evidence of whether probiotics is an effective and safe intervention for coronavirus disease 2019 with diarrhea.PROSPERO registration number CRD42020192657.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Probiotics
/
Diarrhea
/
Betacoronavirus
Type of study:
Experimental Studies
/
Prognostic study
/
Randomized controlled trials
/
Reviews
/
Systematic review/Meta Analysis
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Medicine (Baltimore)
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS